MRX Investors Given Chance to Lead Marex Group plc Securities Fraud Lawsuit

Investors who purchased securities of Marex Group plc (NASDAQ: MRX) between May 16, 2024 and August 5, 2025 now have the opportunity to serve as lead plaintiff in a proposed class action lawsuit, thanks to a notice issued by The Rosen Law Firm, P.A.. The deadline to file a motion to be appointed as lead plaintiff is December 8, 2025. The lawsuit alleges that during the class period, Marex made materially false or misleading statements and failed to disclose key issues: among them, selling over‑the‑counter instruments to itself and inconsistencies between its subsidiaries and related parties in inter‑company receivables and loans. As a result, the company’s financial statements were unreliable and its positive statements about business prospects lacked a reasonable basis. When the truth emerged, investors allegedly suffered losses. Those who purchased Marex securities during the specified timeframe may be eligible for compensation without paying out‑of‑pocket fees or costs, under a contingency‑fee arrangement. Interested parties are advised to contact Rosen Law for details on joining the class action or pursuing the lead plaintiff role. #MarexGroup #SecuritiesFraud #InvestorRights #ClassActionLegal #SlimScan #GrowthStocks #CANSLIM